Coinbase CEO Brian Armstrong is taking on two major challenges: the complexities of human aging and the evolving landscape of cryptocurrency regulation. He’s tackling these issues head-on by […]
NewLimit Secures $130 Million to Drive Age-Reversal Research
Biotech firm NewLimit, co-founded by Coinbase CEO Brian Armstrong, has secured a significant $130 million in funding through a Series B round. This investment from Kleiner Perkins will […]
NewLimit Secures $130 Million Series B Funding to Advance Anti-Aging Research
Biotechnology firm NewLimit has received a significant $130 million Series B funding round, led by the renowned venture capital firm Kleiner Perkins. This investment underscores the potential of […]